Alzheimer's trial

1 statements across 1 episodes · 0 bullish · 0 bearish · 1 people on the record · first statement Nov 14, 2025 by Lada Nuzhna · across every show →

Everything said about Alzheimer's trial, oldest first

Nov 14, 2025 neutral
Assertion Partly supported
Nuzhna: Eli Lilly's Alzheimer's trial tests GLP-1s as broad aging treatments
“I think this month Lilly is reading out their semaglutide in Alzheimer's trial, which is to me is a real test of whether it's An aging drug or not because it's well outside of the metabolic spectrum of diseases.”
Lada Nuzhna Nov 14, 2025 ▶ 36:04 The Brutal Truth About Biotech: Why $2B Per Drug Is Killing Innovation
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 1,000 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.